Seminars

Skaggs Therapeutics: Discovery, Development, Practice and Policy (DDPP) Seminar Series

Held weekly during the Fall, the Skaggs Therapeutics: Discovery, Development, Practice and Policy (DDPP) Seminar Series features world-renowned experts who will discuss all aspects of medicinal research — from discovery to drug pricing — with the goal of sparking new ideas and forging collaborations that improve human health. 

Daniel Nomura

 

Daniel Nomura, Ph.D.

University of California, Berkeley
Professor of Chemical Biology and Molecular Therapeutics, Department of Chemistry and Department of Molecular and Cell Biology
Reimagining Druggability using Chemoproteomic Platforms

Friday, September 27 | Noon-1 pm PT
PSB Room 1120

Margaret Phillips

 

Margaret Phillips, Ph.D.

UT Southwestern Medical Center
Professor and Chair
Department of Biochemistry 
Potent and reversible proteasome inhibitors for the treatment of malaria identified by phenotypic screening

Tuesday, October 1 | 10-11 am PT
PSB Room 1160

Vsevolod "Seva" Katritch

 

Vsevolod "Seva" Katritch, Ph.D.

University of Southern California
Professor
Department of Quantitative & Computational Biology
Department of Chemistry
Co-Director, Center for New Technologies in Drug Discovery and Development
Dana and David Dornsife College of Letters, Arts and Sciences
Michelson Center for Convergent Bioscience
The Bridge Institute
New Computational Approaches to Drug Discovery, Applied Towards Breaking the Cycle of Pain and Addiction

Friday, October 11 | Noon-1 p.m. PT
PSB Room 1120

Thierry Diagana

 

Thierry Diagana, Ph.D.

Novartis
Head of Global Health and California Sites Head Biomedical Research 
Head of the Novartis Institute for Tropical Diseases
Novartis Global Health R&D: Innovating for Underserved Patients

Friday, October 18 | Noon-1 p.m. PT
PSB Room 1120 

Kim D. Janda

 

Kim D. Janda, Ph.D.

Professor
Departments of Chemistry and Immunology
Ely R. Callaway, Jr. Chair in Chemistry Director
Worm Institute of Research and Medicine (WIRM) Scripps Research
A Pharmacokinetic Strategy to Combat the Ultra-Potent Opioids

Friday, October 25 | Noon-1 p.m. PT
PSB Room 1120 

Arnab Chatterjee

 

Arnab Chatterjee, Ph.D.

Scripps Research
Vice President, Medicinal Chemistry, the Calibr-Skaggs Institute for Innovative Medicines
Repurposing Screening to Accelerate Fit-for-Purpose Medicines

Thursday, October 31 | Noon-1 p.m. PT
PSB Room 1120 

Steven Pearson

 

Steven Pearson, M.D., M.Sc.

Founder and Special Advisor
Institute for Clinical and Economic Review
Lecturer, Department of Population Medicine, Harvard Medical School
ICER and the role of drug value assessment to achieve fair pricing and fair access: From the Inflation Reduction Act to new gene therapies

Monday, November 4 | Noon-1 p.m. PT
PSB Room 1120

Dr. Peter Gmeiner

 

Prof Dr. Peter Gmeiner

Chair of Medicinal Chemistry
Department of Chemistry and Pharmacy
Friedrich-Alexander-Universität Erlangen-Nürnberg
Structure-based development of Class A GPCR ligands

Tuesday, November 5 | 1-2 p.m. PT
PSB Room 1170

Ron Dror

 

Ron Dror

Stanford University
Cheriton Family Professor and Professor, by courtesy, of Structural Biology and of Molecular & Cellular Physiology
Simulation and Machine Learning of Biomolecular Structure for the Design of Safe, Effective Drugs

Friday, November 15 | Noon-1 p.m. PT
PSB Room 1120

Fleur M. Ferguson

 

Fleur M. Ferguson, Ph.D.

Department of Chemistry and Biochemistry
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of California San Diego
Interrogating the Druggable Proteome with Proximity Pharmacology

Friday, November 22 | Noon-1 p.m. PT
PSB Room 1120 

Peter J. Turnbaugh

 

Peter J. Turnbaugh, Ph.D.

UCSF 
Professor
Department of Microbiology & Immunology
Towards a pharma[e]cological view of precision medicine

Thursday, December 5 | Noon-1 p.m. PT
PSB Room 1120

William B. Feldman

 

William B. Feldman, M.D., D.Phil., M.P.H.

Harvard Medical School
Assistant Professor of Medicine
Associate Physician, Division of Pulmonary and Critical Care Medicine and Division of Pharmacoepidemiology and Pharmacoeconomics 
Brigham and Women's Hospital 
Associate Physician
Department of Medicine
The High Costs of Inhalers for Asthma and COPD

Friday, December 13 | Noon-1 p.m. PT
PSB Room 1120     

Pradipta Ghosh

 

Pradipta Ghosh, M.D.

UC San Diego School of Medicine
Principal Investigator
Director, Institute for Network Medicine [iNetMed.ucsd.edu]
Executive Director, HUMANOID Center of Research Excellence (CoRE)
Talk Title to Come

Tuesday, December 20 | Noon-1 p.m. PT
PSB Room 1120